Insider track record Other Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Susan Ringdal. Insider active across 1 company, notably Hikma Pharmaceuticals PLC. In total, 16 disclosures have been logged. Activity tracked since 10 August 2023. The latest transaction was disclosed on 1 June 2026 (Vesting). Regulator: RNS (LSE). The full history is accessible without signup.
Declarations 16 total
38,222 shares @ £14.49 20.1% of flow GB00B0LCW083⌘ RNS:9597628-5 76,444 shares @ £14.49 20.1% of flow GB00B0LCW083⌘ RNS:d44dbdfb-743e-4c57-a372-497ad09925dd-5 2,337 shares @ £14.098 1.2% of flow GB00B0LCW083⌘ RNS:549f9a76-e199-4690-8f52-59ddfd93c657-1 Ideal exit: 30 Jan 2027 (T+270) 49,502 shares GB00B0LCW083⌘ RNS:8692df49-f37d-43c7-8ebe-66aeba9a2ed8-5 1,499 shares @ £16.30 1.5% of flow GB00B0LCW083⌘ RNS:5832371-1 Ideal exit: 19 Jun 2026 (T+270) 88,618 shares @ £17.76 31.3% of flow GB00B0LCW083⌘ RNS:5779657 23,433 shares @ £21.38 15.2% of flow GB00B0LCW083⌘ RNS:5680033-5 932 shares @ £20.23 1.8% of flow GB00B0LCW083⌘ RNS:5647004-1 Ideal exit: 31 Jan 2026 (T+270) 38,760 shares GB00B0LCW083⌘ RNS:5613092-5 13,024 shares @ £21.71 10.6% of flow GB00B0LCW083⌘ RNS:5560504-5 3,300 shares @ £19.47 7.5% of flow GB00B0LCW083⌘ RNS:5478623 621 shares @ £19.03 1.7% of flow GB00B0LCW083⌘ RNS:5361694-2 Ideal exit: 20 Jun 2025 (T+270) 906 shares @ £19.34 2.0% of flow GB00B0LCW083⌘ RNS:5176047-1 Ideal exit: 28 Jan 2025 (T+270) 37,974 shares GB00B0LCW083⌘ RNS:5139884-5 26,137 shares @ £18.942 22.4% of flow GB00B0LCW083⌘ RNS:5103062-5 0
100.0% of flow GB00B0LCW083⌘ RNS:4866472